Fidelis Capital Partners’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Buy
11,869
+1,013
+9% +$46.9K 0.03% 318
2026
Q1
$532K Buy
10,856
+382
+4% +$17.8K 0.04% 309
2025
Q4
$457K Buy
10,474
+39
+0.4% +$1.78K 0.03% 329
2025
Q3
$470K Buy
10,435
+45
+0.4% +$1.98K 0.04% 314
2025
Q2
$468K Buy
10,390
+32
+0.3% +$1.43K 0.04% 275
2025
Q1
$479K Buy
10,358
+1,163
+13% +$48.6K 0.05% 255
2024
Q4
$373K Buy
9,195
+3,794
+70% +$147K 0.04% 301
2024
Q3
$220K Buy
+5,401
New +$203K 0.03% 375

Other funds holding EXC

Fidelis Capital Partners's EXC Position: Q2 2026 in Review

Fidelis Capital Partners increased its Exelon (EXC) stake by 9.3% in Q2 2026, buying an estimated $46.9K and bringing the position to 11,869 shares worth $553K. The position accounts for 0.03% of the portfolio, ranked #318.

Fidelis Capital Partners first reported a position in EXC in Q3 2024 and has held it in 8 quarters since. 1,292 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Fidelis Capital Partners held 11,869 shares of Exelon worth $553K as of Q2 2026.
  • Fidelis Capital Partners bought 1,013 Exelon shares in Q2 2026, an estimated $46.9K.
  • Exelon made up 0.03% of Fidelis Capital Partners's portfolio in Q2 2026, its #318 holding.
  • Fidelis Capital Partners first reported a position in Exelon in Q3 2024 and has held it in 8 quarters since.
  • 1,292 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.